Lymphangioleiomyomatosis and TSC2-/- cells - Wikidata - wikimedia - TriplyDB

Lymphangioleiomyomatosis and TSC2-/- cells

Lymphangioleiomyomatosis and TSC2-/- cells

http://www.wikidata.org/entity/Q33904951

about

Real-time monitoring of tumorigenesis, dissemination, & drug response in a preclinical model of lymphangioleiomyomatosis/tuberous sclerosis complex Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models The new era of the lymphatic system: no longer secondary to the blood vascular system Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase.Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM)Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene Leiomyoma and leiomyoma cellulare of the fallopian tube: review of the literature and case reports.Treatment option(s) for pulmonary lymphangioleiomyomatosis: progress and current challenges.Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

P2860

Q27301399-1A35BBF4-1844-4DA4-B232-1FC013F0C652 Q27687650-1C0E20EA-4B4C-4A25-8CE9-18E6DFA2D0F1 Q35852994-29D25E12-0988-4F93-AB99-37D1C0247DE4 Q36232850-D54FDE75-0E4C-44F2-A189-F4230025033C Q36411134-B04438FB-7F11-4496-978A-789CC5D2BF76 Q36636671-75C1AD66-D32B-48DC-B9F9-21D2BB506F4C Q37057152-4DA70B68-B6A1-4AC7-93E8-219D46A63700 Q37149062-EBD15001-E3DC-4F36-8A1D-E27790A9ECC1 Q37473118-DCC9F557-C872-4224-80DE-9BFBC46EF5F2 Q43182213-E554A247-BAC9-4A41-A383-697FC222DCD1 Q47662133-B84F0059-4C17-46DD-8C8E-1BE3C6D1A9BB

P2860

Lymphangioleiomyomatosis and TSC2-/- cells

http://www.wikidata.org/entity/Q33904951

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Lymphangioleiomyomatosis and TSC2-/- cells

@ast

Lymphangioleiomyomatosis and TSC2-/- cells

@en

type

label

Lymphangioleiomyomatosis and TSC2-/- cells

@ast

Lymphangioleiomyomatosis and TSC2-/- cells

@en

prefLabel

Lymphangioleiomyomatosis and TSC2-/- cells

@ast

Lymphangioleiomyomatosis and TSC2-/- cells

@en

P1433

Q33904951-3F1B1569-5CE9-4CCD-B49D-1EA519CDA54B

P1476

Q33904951-2387DDC3-9796-410C-BB7F-D8ACFC2DE6F0

P2093

Q33904951-099F483E-99DF-4C40-A4ED-85D1B687FF88

Q33904951-1924C30E-6581-4F4E-A476-B5437D47C6D6

Q33904951-9C5F5E90-E861-4C15-B3D7-F44913077C92

Q33904951-B715A77F-E846-47C7-8301-06528C363A14

P2860

Q33904951-0243825E-C4DB-4EF8-937D-C2FDC56EE83A

Q33904951-02AC579D-8720-4A0D-BCD2-9651BEB7320D

Q33904951-0339B2C0-2CFE-468E-B3B7-DBA3D9C8C103

Q33904951-0569B17B-E414-42D9-B3E1-C4FECBB77B88

Q33904951-0B9A261F-2841-4E4C-8D6C-A0E983B261BA

Q33904951-0D3A9CB9-B67C-460F-8D07-CD8991A3639E

Q33904951-0DB26EEA-0CED-48F9-8D25-0954515F97C4

Q33904951-11E2EB0F-D3E5-428E-88A4-AF145EA060CA

Q33904951-150FA0D1-7F29-4056-8899-B282EFAF544C

Q33904951-1963025A-C7B5-4787-8616-59A0779B39FC

P304

Q33904951-FEEFC163-5C78-4854-939A-8F6EBF702A16

P31

Q33904951-86CBE97B-5676-4878-80F6-57C5601BE6F5

P356

Q33904951-D5F676E1-0A97-4865-9428-247AF403281A

P433

Q33904951-4F3F4D48-7B87-4EA0-A6B6-B19FA58668AF

P478

Q33904951-B5B0606E-EDCE-4A0A-A9FA-3D153E0830CB

P50

Q33904951-6ED42F3C-FE6B-4A1D-900B-5CAE34B7C5C8

Q33904951-ACF21B58-02F5-4BCE-9269-27FAF7E61ED4

P577

Q33904951-69DFA985-79A8-4F64-9242-71274920FE73

P5875

Q33904951-140B8482-268F-41A6-915B-C59CB1BE9BF0

P698

Q33904951-11D06915-911A-4778-A1E5-3EF34D89082A

P932

Q33904951-A7226DB5-4A7B-4432-B92F-E9E5B0AAB5E5

P356

P1433

Lymphatic Research and Biology

P1476

Lymphangioleiomyomatosis and TSC2-/- cells

@en

P2093

Alfredo Gorio

http://www.w3.org/2001/XMLSchema#string

Cheryl Walker

http://www.w3.org/2001/XMLSchema#string

Gustavo Pacheco-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Joel Moss

http://www.w3.org/2001/XMLSchema#string

P2860

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene

PEComas: the past, the present and the future

Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas

MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors

Adenoma sebaceum of Pringle: a clinicopathologic review, with a discussion of related pathologic entities

The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background

P304

59-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/LRB.2009.0031

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Thomas N. Darling

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42253950

http://www.w3.org/2001/XMLSchema#string

P698

20235888

http://www.w3.org/2001/XMLSchema#string

P932

2883471

http://www.w3.org/2001/XMLSchema#string